Scientists identify the neuroblastoma cells that signal poor outcomes

Neuroblastoma is the most common solid tumor found outside the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood. St. Jude ...
Yahoo Finance

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]

UXBRIDGE, England, April 17, 2025 /CNW/ -- Norgine is pleased to announce that the Australian Therapeutic Goods Administration (TGA) has approved the registration of IFINWIL® (eflornithine) for the ...
Medical Xpress

Drug targeting RNA modifications shows promise for treating neuroblastoma

Neuroblastoma is a common pediatric cancer that originates in developing nerve cells outside the brain. While increasingly intensive treatments have improved the survival of patients with high-risk ...
Medscape

Patients With Neuroblastoma See Long-Term Survival Post-PARP Inhibitor, CAR T-Cell Treatments

In 2017, Stephanie Uy learned that her 22-month-old daughter, Aspen, had stage IV high-risk neuroblastoma. The cancer, which develops from the sympathetic nervous system, is the most common type of ...
Medical Xpress

Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma

The average age of diagnosis is about 18 months but occasionally the disease is seen in teens and young adults. Neuroblastoma has a high mortality rate and despite extensive studies, the malignant ...
Yahoo Finance

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]

The average survival rate of children with HRNB is only 50% 2 ...